Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies Post author:Sam Post published:November 19, 2017 Post category:BioPharma Data will be submitted to health authorities globally, including the FDA and EMA. Source: BioSpace You Might Also Like Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued March 23, 2017 Ceapro Reports 2016 Financial Results And Provides Corporate Update April 5, 2017 Former Celator CPA Connived With Two Friends, Father on Insider-Trading Scheme August 31, 2017
